TRCT
HHS icon

Tower Research Capital (TRC)’s Harte-Hanks HHS Stock Holding History

Tower Research Capital (TRC)’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73K Sell
1,725
-270
-14% -$706 ﹤0.01% 4487
2026
Q1 		$4.53K Buy
1,995
+857
+75% +$2.43K ﹤0.01% 4187
2025
Q4 		$3.42K Buy
+1,138
New +$3.72K ﹤0.01% 4370
2025
Q3 		– Sell
-15
Closed -$60 – 5380
2025
Q2 		$60 Buy
+15
New +$67 ﹤0.01% 5186
2025
Q1 		– Sell
-266
Closed -$1.37K – 5447
2024
Q4 		$1.37K Buy
266
+223
+519% +$1.44K ﹤0.01% 5036
2024
Q3 		$320 Sell
43
-906
-95% -$7.11K ﹤0.01% 5379
2024
Q2 		$7.71K Buy
949
+756
+392% +$5.51K ﹤0.01% 4433
2024
Q1 		$1.44K Buy
+193
New +$1.47K ﹤0.01% 5264
2023
Q4 		– Sell
-500
Closed -$3.25K – 6025
2023
Q3 		$3.25K Sell
500
-620
-55% -$3.63K ﹤0.01% 5029
2023
Q2 		$6.14K Sell
1,120
-1,216
-52% -$8.28K ﹤0.01% 4734
2023
Q1 		$22K Sell
2,336
-8,342
-78% -$92.1K ﹤0.01% 3334
2022
Q4 		$125K Sell
10,678
-1,308
-11% -$14.5K 0.01% 1655
2022
Q3 		$134K Buy
11,986
+11,552
+2,662% +$154K ﹤0.01% 2287
2022
Q2 		$6K Sell
434
-10,373
-96% -$90.8K ﹤0.01% 4927
2022
Q1 		$82K Buy
10,807
+10,717
+11,908% +$76.7K ﹤0.01% 2360
2021
Q4 		$1K Buy
+90
New +$715 ﹤0.01% 5827
2020
Q2 		– Sell
-217
Closed – – 4838
2020
Q1 		$0 Buy
217
+159
+274% +$473 ﹤0.01% 3404
2019
Q4 		$0 Sell
58
-24
-29% -$71 ﹤0.01% 3858
2019
Q3 		$0 Buy
+82
New +$258 ﹤0.01% 4268
2019
Q2 		– Sell
-7,294
Closed -$26K – 3929
2019
Q1 		$26K Sell
7,294
-1,022
-12% -$3.56K ﹤0.01% 2122
2018
Q4 		$20K Buy
8,316
+5,264
+172% +$25.1K ﹤0.01% 1934
2018
Q3 		$22K Sell
3,052
-638
-17% -$5.61K ﹤0.01% 2285
2018
Q2 		$41K Buy
3,690
+2,600
+239% +$26.6K ﹤0.01% 1950
2018
Q1 		$10K Buy
+1,090
New +$9.97K ﹤0.01% 2466
2017
Q4 		– Sell
-2,569
Closed -$28K – 3717
2017
Q3 		$28K Sell
2,569
-1,870
-42% -$17.2K ﹤0.01% 2495
2017
Q2 		$45K Sell
4,439
-294
-6% -$3.71K 0.01% 796
2017
Q1 		$66K Buy
4,733
+1,800
+61% +$27.4K 0.01% 619
2016
Q4 		$44K Buy
2,933
+1,273
+77% +$19.3K ﹤0.01% 1505
2016
Q3 		$27K Sell
1,660
-3,912
-70% -$64.4K ﹤0.01% 1451
2016
Q2 		$88K Buy
5,572
+5,132
+1,166% +$90.6K 0.01% 1196
2016
Q1 		$11K Buy
440
+16
+4% +$491 ﹤0.01% 1858
2015
Q4 		$14K Buy
424
+126
+42% +$4.72K ﹤0.01% 1693
2015
Q3 		$11K Sell
298
-379
-56% -$17.1K ﹤0.01% 2221
2015
Q2 		$41K Buy
677
+554
+450% +$37.3K ﹤0.01% 1523
2015
Q1 		$10K Buy
+123
New +$9.51K ﹤0.01% 2786
2014
Q4 		– Sell
-678
Closed -$43K – 4283
2014
Q3 		$43K Buy
678
+628
+1,256% +$42.7K ﹤0.01% 1660
2014
Q2 		$4K Sell
50
-105
-68% -$8.11K ﹤0.01% 2994
2014
Q1 		$14K Buy
155
+115
+288% +$8.95K ﹤0.01% 2249
2013
Q4 		$3K Sell
40
-50
-56% -$4.08K ﹤0.01% 3840
2013
Q3 		$8K Sell
90
-541
-86% -$49.5K ﹤0.01% 3354
2013
Q2 		$54K Buy
+631
New +$52.2K ﹤0.01% 870

Other funds holding HHS

William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $542M AUM 48.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
RA
Raffles Associates New York $117M AUM 22.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tower Research Capital (TRC)'s HHS Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Harte-Hanks (HHS) stake by 14% in Q2 2026, selling an estimated $706 and leaving 1,725 shares worth $3.73K. The position accounts for ﹤0.01% of the portfolio, ranked #4487.

Tower Research Capital (TRC) first reported a position in HHS in Q2 2013 and has held it in 41 quarters since. The position peaked at $134K in Q3 2022. 22 funds tracked by Wall St. Rank hold HHS as of Q2 2026.

  • Tower Research Capital (TRC) held 1,725 shares of Harte-Hanks worth $3.73K as of Q2 2026.
  • Tower Research Capital (TRC) sold 270 Harte-Hanks shares in Q2 2026, an estimated $706.
  • Harte-Hanks made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4487 holding.
  • Tower Research Capital (TRC) first reported a position in Harte-Hanks in Q2 2013 and has held it in 41 quarters since.
  • Tower Research Capital (TRC)'s Harte-Hanks position peaked at $134K in Q3 2022.
  • 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.